Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Abeona Therapeutics Inc.

NASDAQ: ABEOHealthcare / Biotechnology / USA
6.63+0.1300+2.00%Vol 303 4591Y Perf -44.98%
Feb 15th, 2019 16:00
BID6.63 ASK6.64
Open6.52 Previous Close6.50
Pre-Market- After-Trading6.63
 - -%  - -%
Target Price
26.38 
Analyst Rating
Strong Buy 1.00
Potencial %
297.89 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)318 
Earnings Rating
Strong Sell
Price Range Ratio 52wk %
2.35 
Earnings Date
15th Mar 2019

Today's Price Range

6.336.68

 

52wk Range

6.2622.00

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Buy
Performance
1 Month
-5.56%
3 Months
-19.64%
6 Months
-51.61%
1 Year
-44.98%
3 Years
166.27%
5 Years
-59.82%

Quotes

Name / TickerPriceChg.Chg.%
ABEO6.630.13002.00
AAPL170.42-0.3800-0.22
GOOG1 113.65-8.0200-0.72
MSFT108.221.32001.23
XOM77.711.44001.89
WFC49.220.70001.44
JNJ136.382.07001.54
FB162.50-1.4500-0.88
GE10.090.05000.50
JPM105.553.13003.06
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
10.90
Current Ratio
11.10
Long Term Debt to Total Capital
-
Total Debt to Equity
-
Interest Coverage
-4 502.20
Leverage Ratio 1.00
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
-
EBIT Margin
-843.00
EBITDA Margin
-822.10
Pre-tax Profit Margin
-2 656.00
Profit Margin
-
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
2.08
PS Ratios
61.08
Price to Cash Flow
30.10
Price to Free Cash Flow
-10.20
Cash Flow Per Share
-0.59
Price to Tangible Book
2.74
Book Value per Share
3.13
Enterprise Value (in ths.)
200 853
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
-39.35
ROE last 12 Months
-37.51
Return on Assets (5Y Avg)
-14.33
ROA last 12 Months
-35.14
Return on Capital (5Y Avg)
-
ROC last 12 Months
-38.56
Return on invested Capital Q
-10.87
Return on invested Capital Y
-20.68
Assets Turnover
0.00
Receivables Turnover
12.60
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
5 126
Revenue per Share
0.11
Revenue Growth 3 Years
40.86
Revenue Growth 5 Years
4.80
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 2018-0.23-0.34-47.83
Q02 2018-0.16-0.25-56.25
Q01 2018-0.19-0.185.26
Q04 2017-0.13-0.19-46.15
Q03 2017-0.18-0.1327.78
Q02 2017-0.13-0.21-61.54
Q01 2017-0.13-0.130.00
Q04 2016-0.13-0.19-46.15
Earnings Per EndEstimateRevision %Trend
12/2018 QR-0.42-82.61Negative
12/2018 FY-1.13-22.83Negative
3/2019 QR-0.27-42.11Negative
12/2019 FY-1.47-81.48Negative
Next Report Date15th Mar 2019
Estimated EPS Next Report-0.42
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume303 459
Shares Outstanding (in ths.)47 944
Trades Count1 384
Dollar Volume1 680 402
Avg. Volume380 590
Avg. Weekly Volume326 853
Avg. Monthly Volume380 608
Avg. Quarterly Volume564 145

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

0%100%

Bearish Bullish

53%47%

Bearish Bullish

55%45%

Bearish Bullish

63%37%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
8 (100.00 %)
8 (100.00 %)
6 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News